Incyte secures FDA nod for Opzeluras pediatric use in atopic dermatitis, marking its third U.S. approval and boosting sales ...

Researchers have analyzed available topical and systemic treatments for eczema and identified the ones that are most effective. They say their findings present a full range of treatment options to ...

The US FDA has approved ruxolitinib (Opzelura) cream 1.5% for the short-term and noncontinuous chronic treatment of ...

Atopic dermatitis is one of the most common chronic inflammatory skin diseases worldwide and is also the most common form of eczema. Although infants and children are most often affected, adults can ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...

The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

Nurse Kathryn Tullos immediately noticed something was different about her youngest son’s eczema symptoms. She and her three other children had all suffered from eczema, so she was well-acquainted ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Pimecrolimus, ...

People with atopic dermatitis are taking to social media to share dramatic images of red, cracked, peeling skin that they blame on overuse of steroid creams. But their dermatologists may not agree.

Up until a few years ago, Heather Sullivan’s 14-year-old son, Sawyer, had struggled with eczema his entire life. When he was just a baby, most of his body would be covered in intensely itchy rashes ...

There are seven types of eczema. While they're all pretty similar, dermatologists say treatment can vary depending on the type. Our editors independently select these products. Making a purchase ...